Evidence map›Paper›PMID 33857686›Full record

ArticleNanomedicine : nanotechnology, biology, and medicine2021

Mild magnetic nanoparticle hyperthermia promotes the disaggregation and microglia-mediated clearance of beta-amyloid plaques.

Eric Dyne, Praneetha Sundar Prakash, Junfeng Li, Bing Yu, Thorsten-Lars Schmidt, Songping Huang, Min-Ho Kim

Open access · greenAbstract read
In one paragraph

Article in Nanomedicine : nanotechnology, biology, and medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Eric DyneSchool of Biomedical Sciences, Kent State University, Kent, OH, USA.
Praneetha Sundar PrakashSchool of Biomedical Sciences, Kent State University, Kent, OH, USA; Department of Physics, Kent State University, Kent, OH, USA.
Junfeng LiDepartment of Chemistry and Biochemistry, Kent State University, Kent, OH, USA.
Bing YuDepartment of Biological Sciences, Kent State University, Kent, OH, USA.
Thorsten-Lars SchmidtSchool of Biomedical Sciences, Kent State University, Kent, OH, USA; Department of Physics, Kent State University, Kent, OH, USA.
Songping HuangDepartment of Chemistry and Biochemistry, Kent State University, Kent, OH, USA.
Min-Ho KimSchool of Biomedical Sciences, Kent State University, Kent, OH, USA; Department of Biological Sciences, Kent State University, Kent, OH, USA. Electronic address: mkim15@kent.edu.
Kent State University · US

Funding

Targeted magnetic nanoparticle hyperthermia for minimally invasive disruption of amyloid beta plaques towards the treatment of Alzheimer's diseaseR01NR015674 · NINR · KENT STATE UNIVERSITY · PI KIM, MIN HO · 2015 to 2019
$2.2M
NINR NIH HHS R01 NR015674
6 · The paper itself

Abstract

The formation of beta-amyloid (Aβ) plaques is a classical hallmark of Alzheimer's disease (AD) that is associated with the promotion of neuroinflammation and subsequent neurotoxicity. Given the limited therapeutic options for targeting and clearing Aβ plaques in AD, there is an urgent need to develop effective approaches to reduce plaque accumulation. The objective of this study was to validate mild magnetic nanoparticle (MNP) hyperthermia technology as a strategy to clear Aβ deposits and determine the impact on microglia functionality. Our results demonstrated that the heating of MNPs localized to Aβ aggregates upon exposure to high frequency alternating magnetic field (AMF) was sufficient to disrupt Aβ plaques, resulting in its fragmentation. Importantly, this could facilitate the phagocytic clearance of Aβ as well as attenuate pro-inflammatory responses by human microglial cells. Our results support the feasibility of mild MNP/AMF hyperthermia as a new strategy for reducing beta-amyloid burdens in Alzheimer's disease.

Indexed as

MagneticsNanoparticlesAmyloid beta-PeptidesCell Line, TransformedHumansHyperthermia, InducedMicrogliaMicroscopy, Electron, ScanningPhagocytosisPlaque, AmyloidAmyloid beta-PeptidesBeta-amyloidHyperthermiaMagnetic nanoparticlesMicroglia

Identifiers

PMID33857686
PMCPMC8217164
OpenAlexW3156541047

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.